News and Views


Nature Medicine 13, 129 - 131 (2007)
doi:10.1038/nm0207-129

Seeing what Alzheimer saw

Mony J de Leon1, Lisa Mosconi1 & Jean Logan1

  1. M.J. de Leon is at the Center for Brain Health at the New York University School of Medicine, 560 First Avenue, New York, New York 10016, USA, Nathan Kline Institute, Orangeburg, New York 10962, USA. e-mail: mony.deleon@med.nyu.edu
  2. L. Mosconi is at the Center for Brain Health at the New York University School of Medicine, 560 First Avenue, New York, New York 10016, USA.
  3. J. Logan is at the Brookhaven National Lab, Upton, New York 11973 USA.


The ability to visualize brain pathology in living individuals with Alzheimer disease could change how the disease is diagnosed and drugs to treat it tested. A recently developed positron emission tomography tracer helps to image fibrillar amyloid-beta and neurofibrillary tangles and brings us closer to this goal.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Seeing what Alzheimer saw

Nature Medicine News and Views (01 Feb 2007)

Pinpointing plaques with PIB

Nature Medicine News and Views (01 Jul 2006)

See all 12 matches for News And Views

Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

  • Delayed Burst Release

    • Deadline: Mar 04 2010
    • Reward: $20,000 USD

    A mechanism is desired that will have little or no release until triggered and then substantially re...

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

naturejobs

ADVERTISEMENT